POSTER: MPN-628 Surpass-ET: Ropeginterferon Alfa-2b (P1101) vs Anagrelide as Second Line Therapy in Essential Thrombocythemia
Clinical Lymphoma, Myeloma & Leukemia（2023）
关键词
MPN,essential thrombocythemia,myeloproliferative neoplasm,ropeginterferon alfa-2b-njft,anagrelide,interferon,phase III,trial-in-progress
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要